Evan Y. Yu, MD, discusses how the goals of therapy for a patient with newly- diagnosed metastatic hormone-sensitive prostate cancer are to control disease progression, extend survival, maintain quality of life, and delay the transition to castration-resistant prostate cancer.
Video content above is prompted by the following:
What are the goals of therapy for a patient like such as this with newly-diagnosed metastatic hormone-sensitive prostate cancer?